Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Total Current Liabilities (2016 - 2025)

ENDRA Life Sciences has reported Total Current Liabilities over the past 6 years, most recently at $1.5 million for Q4 2021.

  • Quarterly Total Current Liabilities rose 56.46% to $1.5 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2021, up 56.46% year-over-year, with the annual reading at $1.5 million for FY2021, 56.46% up from the prior year.
  • Total Current Liabilities was $1.5 million for Q4 2021 at ENDRA Life Sciences, down from $1.6 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $2.1 million in Q4 2019 and troughed at $162302.0 in Q2 2017.
  • The 5-year median for Total Current Liabilities is $1.4 million (2020), against an average of $1.3 million.
  • Year-over-year, Total Current Liabilities soared 112.68% in 2019 and then crashed 52.4% in 2020.
  • A 5-year view of Total Current Liabilities shows it stood at $848214.0 in 2017, then increased by 14.9% to $974583.0 in 2018, then skyrocketed by 112.68% to $2.1 million in 2019, then crashed by 52.4% to $986663.0 in 2020, then surged by 56.46% to $1.5 million in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Total Current Liabilities are $1.5 million (Q4 2021), $1.6 million (Q3 2021), and $1.6 million (Q2 2021).